Related Experiment Video
Updated: Apr 18, 2026

A Saline/Bipolar Radiofrequency Energy Device As an Adjunct for Hemostasis in Solid Organ Injury/Trauma
Published on: July 28, 2020
Tranexamic acid: from trauma to routine perioperative use
Jeff Simmons1, Robert A Sikorski, Jean-Francois Pittet
1aAnesthesia Services Division, Trauma Section, UAB Department of Anesthesiology, Birmingham, Alabama bDivision of Trauma Anesthesiology, Department of Anesthesiology, University of Maryland School of Medicine, and Perfusion and Cell Salvage Services, R Adams Cowley Shock Trauma Center, Baltimore, Maryland cCritical Care Division, Department of Anesthesiology, and Surgery and Cell Biology, Center for Lung Injury and Repair, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Purpose Of Review:
Optimizing hemostasis with antifibrinolytics is becoming a common surgical practice. Large clinical studies have demonstrated efficacy and safety of tranexamic acid (TXA) in the trauma population to reduce blood loss and transfusions. Its use in patients without pre-existing coagulopathies is debated, as thromboembolic events are a concern. In this review, perioperative administration of TXA is examined in nontrauma surgical populations. Additionally, risk of thromboembolism, dosing regimens, and timing of dosing are assessed.
Recent Findings:
Perioperative use of TXA is associated with reduced blood loss and transfusions. Thromboembolic effects do not appear to be increased. However, optimal dosing and timing of TXA administration is still under investigation for nontrauma surgical populations.
Summary:
As part of a perioperative blood management programme, TXA can be used to help reduce blood loss and mitigate exposure to blood transfusion.
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Venous Thrombosis III: Interprofessional Care
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Local Anesthetics: Clinical Application as Intravenous Regional Anesthesia
One of the advantages of...
Introduction to Hemostasis
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
Aneurysm IV: Nursing Management

